Iron treatment and vaccine response in anemic Kenyan infants
Part of Hormones & metabolism, Infections clinical trials.
This study tests whether giving iron to iron-deficient babies in Kenya helps them respond better to malaria and measles vaccines. It aims to improve vaccine protection in this group.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is 6 months old (give or take 2 weeks).
- Your baby has low iron levels (iron deficiency).
- You (the mother) are at least 15 years old.
- Your baby has not received any iron supplements in the last 2 weeks.
- Your baby does not have a serious infection like HIV or severe wasting.
- Your baby has not already received a malaria vaccine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding extra iron to ready-to-use therapeutic foods helps malnourished children recover faster. It compares outcomes in children with severe or moderate malnutrition and healthy children.
This study looks at how well pregnant women in Kenya absorb iron from two types of supplements during the second trimester. It aims to find which supplement works best for you and your baby.
This trial is testing whether giving the R21 malaria vaccine to infants at different ages (starting at 2 months or 3 months) works as well as starting at 6 weeks. It will help find the best schedule to protect babies against malaria.
This trial tests whether taking a daily multivitamin and mineral supplement during pregnancy can prevent anemia in mothers living in Tanzania. If you are pregnant, under 20 weeks along, and at least 18 years old, you may be able to join.
This study tests whether giving iron and choline (a nutrient important for brain development) can improve brain health in babies with low iron. It is for 5- to 7-month-olds who are still breastfeeding.
This Phase 1/2 study tests a new vaccine meant to protect young children against malaria. If you qualify, your baby would get the study vaccine and be followed for about 12 months to check safety and early signs of protection.
Hear when a new Iron Deficiencies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.